Safety Reporting Requirements for INDs and BA/BE Studies: Guidance for Industry and Investigators
Detailed guidance document from FDA and regulatory agencies.
Document Details
Small Entity Compliance Guide
October 19, 2026
October 19, 2026
f29cb314-c037-401d-9e00-b73921e58aee
Related Documents
Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products: Questions and Answers
Small Entity Compliance GuideOctober 9, 2026Center for Drug Evaluation and Research
Questions and Answers on Biosimilar Development and the BPCI Act: Guidance for Industry
Small Entity Compliance GuideOctober 9, 2026Center for Drug Evaluation and Research
Postapproval Pregnancy Safety Studies: Guidance for Industry
Small Entity Compliance GuideMay 8, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.